However, there is still the possibility of cholesterol depletion agents causing toxicity in humans, and in vivo studies of tumours are required to confirm the work of Zhuang et al. [97] regarding the link between high cholesterol, elevated signalling through the EGFR, and prostate cancer incidence/progression. Here, EGFR is linked to neoplasm.